CJC-1295 No DAC research evidence: what has actually been studied?
A neutral review of CJC-1295 No DAC research and the critical distinction from long-acting DAC-conjugated CJC-1295 studies.
Read ArticleAGE & RESEARCH-USE CONFIRMATION
JD BioWorks supplies materials solely for qualified laboratory and analytical research. Products are not for human consumption or human or veterinary use.
Review the Terms and Conditions.
LOT-SPECIFIC DOCUMENTATION
Each link opens the matching laboratory report for the labeled quantity shown. Analytical results describe the tested lot and do not establish safety, efficacy, sterility, or suitability for human or veterinary use.
Report / batch: COA-2026-UDP41T / Lot 2026-002
Method: Purity, Identity & Quantitation (HPLC)
Reported results: PASS — 99.46% peptide purity; 10.69 mg net blend peptide content; CJC-1295 (No DAC) and Ipamorelin identities confirmed by HPLC-RTM; fentanyl not detected. Lab verification access code: E8BGUCDW.
View matching Certificate of AnalysisLot-specific Certificates of Analysis are linked below for the labeled quantities currently available.
Methods shown in current reports: Purity, Identity & Quantitation (HPLC)
For qualified laboratory research only. Not for human consumption or human or veterinary use.
Pricing and ordering require a confirmed Research Access account.